Bumper Offer - Urjas oil Just @ Rs. 1
Basalog Injection 10ml (1) is a commercial drug that is prescribed in the form of Injection. Primarily, it is used for the treatment of Diabetes Type 1, Diabetes Type 2. Secondary and off-label uses of Basalog Injection 10ml (1) have also been mentioned below.
The correct dosage of Basalog Injection 10ml (1) depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Basalog Injection 10ml (1) have been listed ahead. Usually, these side effects of Basalog Injection 10ml (1) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Basalog Injection 10ml (1)'s effect is Safe during pregnancy and Mild for lactating mothers. In addition, Basalog Injection 10ml (1)'s effects on the liver, heart and kidney are discussed below in the Basalog Injection 10ml (1) related warnings section.
Other conditions have been mentioned below in the Basalog Injection 10ml (1) contraindications section.
Drug reaction of Basalog Injection 10ml (1) with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Basalog Injection 10ml (1) is considered not safe while driving, and is not addictive.
Basalog Injection 10ml (1) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Basalog Injection 10ml (1) is used -
Moderate
Mild
Is the use of Basalog Injection 10ml (1) safe for pregnant women?
There are no side effects of Basalog in pregnant women.
Is the use of Basalog Injection 10ml (1) safe during breastfeeding?
Basalog may have very limited harmful effects for breastfeeding women.
What is the effect of Basalog Injection 10ml (1) on the Kidneys?
There can be some harmful effects on your kidneys after taking Basalog. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Basalog Injection 10ml (1) on the Liver?
Basalog may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Basalog Injection 10ml (1) on the Heart?
Basalog is rarely harmful for the heart.
Basalog Injection 10ml (1) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Basalog Injection 10ml (1) unless your doctor advises you to do so -
Is this Basalog Injection 10ml (1) habit forming or addictive?
No, you will not get addicted to Basalog Injection 10ml (1).
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Basalog Injection 10ml (1) can make you feel drowsy.
Is it safe?
Yes, but consume Basalog Injection 10ml (1) only on doctor's advice.
Is it able to treat mental disorders?
No, Basalog Injection 10ml (1) cannot treat any kind of mental disorder.
Interaction between Food and Basalog Injection 10ml (1)
Due to the absence of research, it is difficult to say how Basalog Injection 10ml (1) and food will interact.
Interaction between Alcohol and Basalog Injection 10ml (1)
Side effects of drinking alcohol and taking Basalog Injection 10ml (1) at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)